NeoGenomics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
NeoGenomics, Inc. (NEO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $1.83 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2026-02-17
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $1.83M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $14.70M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $15.57M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $1.40M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2025-12-31 | $1.83M 10-K · filed 2026-02-17 |
| 2024-12-31 | $14.70M 10-K · filed 2025-02-18 |
| 2023-12-31 | $15.57M 10-K · filed 2024-02-20 |
| 2022-12-31 | $1.40M 10-K · filed 2023-02-24 |
| 2021-12-31 | $36.10M 10-K · filed 2022-02-25 |
| 2020-12-31 | $146.30M 10-K · filed 2021-02-25 |
| 2019-12-31 | $102.50M 10-K · filed 2020-02-28 |
| 2018-12-31 | $34.40M 10-K · filed 2019-02-26 |
| 2017-12-31 | $14.90M 10-K · filed 2018-03-13 |
| 2016-12-31 | $14.50M 10-K · filed 2017-03-14 |
| 2015-12-31 | $25.50M 10-K · filed 2016-04-18 |
| 2014-12-31 | $8.80M 10-K · filed 2015-03-03 |
| 2013-12-31 | $13.80M 10-K · filed 2014-02-24 |
| 2012-12-31 | $8.40M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |